Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biosyent Inc (RX.VN)

Biosyent Inc (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biosyent Inc 2476 Argentia Road Suite 402 Mississauga ON L5N 6M1 CAN

www.biosyent.com P: 905-206-0013 F: 905-206-1413

Description:

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Key Statistics

Overview:

Market Capitalization, $K 99,806
Shares Outstanding, K 11,605
Annual Sales, $ 31,590 K
Annual Net Income, $ 6,460 K
Last Quarter Sales, $ 8,274 K
Last Quarter Net Income, $ 1,451 K
60-Month Beta 0.40
% of Institutional Shareholders 1.39%

Growth:

1-Year Return 14.34%
3-Year Return 11.41%
5-Year Return 14.64%
5-Year Revenue Growth 7.97%
5-Year Earnings Growth 6.37%

Per-Share Information:

Latest Earnings Date 05/24/24
Earnings Per Share ttm 0.53
EPS Growth vs. Prev Qtr -37.95%
EPS Growth vs. Prev Year 0.22%
Annual Dividend Rate, $ 0.16
Annual Dividend Yield 2.09%
Most Recent Dividend 0.045 on 02/28/24
Next Ex-Dividends Date 02/28/24
Dividend Payable Date 03/15/24
Dividend Payout Ratio 30.13%

RX.VN Ratios

Ratio
Price/Earnings ttm 16.20
Price/Earnings forward 18.28
Price/Earnings to Growth N/A
Return-on-Equity % 18.97%
Return-on-Assets % 15.75%
Profit Margin % 20.45%
Debt/Equity 0.03
Price/Sales 3.35
Price/Book 2.87
Book Value/Share 3.00

RX.VN Dividends

Date Value
02/28/24 $0.0450
11/29/23 $0.0400
08/30/23 $0.0400
06/01/23 $0.0400
02/27/23 $0.0400
11/29/22 $0.0400
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar